Evrima transforms the recruitment process for clinical trials to help clinicians accelerate timelines and increase patient awareness.
Evrima Technologies has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in September 2022.
Evrima Technologies's investors include Wavemaker Ventures, Artesian VC, BridgeLane Capital.
Evrima Technologies is headquartered in Leichhardt, Australia.
Evrima transforms the recruitment process for clinical trials to help clinicians accelerate timelines and increase patient awareness.
Evrima Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evrima Technologies — Funding & Investors." VCBacked, September 5, 2022, https://www.vcbacked.co/company/evrima-technologies. Accessed July 21, 2026.
VCBacked. (2022). Evrima Technologies — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/evrima-technologies
{{cite web |title=Evrima Technologies — Funding & Investors |url=https://www.vcbacked.co/company/evrima-technologies |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated